CurrentPartnering Research Reports

Title	Published	Price
Discovery Stage Partnering Agreements in Biopharma By: CurrentPartnering The Discovery Stage Partnering Agreements in Biopharma report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding \| more...	9/1/2008	$2,395.00
Wyeth Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Wyeth as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Watson Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Watson as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
UCB Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of UCB as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Teva Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Teva as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Takeda Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Takeda as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Solvay Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Solvay as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Shire Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Shire as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Schering Plough Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Schering-Plough as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Sanofi-Aventis Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Sanofi-Aventis as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Roche Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Roche as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Procter & Gamble Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Procter & Gamble as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents \| more... Search inside this report	7/1/2008	$395.00
Pfizer Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Pfizer as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Otsuka Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Otsuka as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Nycomed Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Nycomed as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Novo Nordisk Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Novo Nordisk as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed \| more... Search inside this report	7/1/2008	$395.00
Novartis Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Novartis as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Mitsubishi Tanabe Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Mitsubishi Tanabe as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed \| more... Search inside this report	7/1/2008	$395.00
Merck Serono Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Merck Serono as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed \| more... Search inside this report	7/1/2008	$395.00
Merck Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Merck & Co as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents \| more...	7/1/2008	$395.00
Lundbeck Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Lundbeck as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
King Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of King Pharmaceuticals as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed \| more... Search inside this report	7/1/2008	$395.00
Johnson & Johnson Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Johnson & Johnson as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents \| more... Search inside this report	7/1/2008	$395.00
GlaxoSmithKline Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of GlaxoSmithKline as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Genzyme Pharma Partnering Guide 2008 By: CurrentPartnering Using this report, dealmakers will effectively and efficiently determine the suitablility of Genzyme as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with \| more... Search inside this report	7/1/2008	$395.00
Title	Published	Price

< prev 1 2 3 4 5 next >

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2008, All Rights Reserved, MarketResearch.com
9/7/2008 - 4